Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha,
Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha, NE, firm named Merl Dunham technical director of its imaging information and integration division. Dunham will manage CDIs integration lab and personnel and will provide technical support and integration coordination. He will report to Marty Huebner, vice president of service. CDI also appointed Randy Wobig to the post of clinical network specialist. Wobig will oversee CDIs networking department. Finally, CDIs subsidiary, Integrated Equipment Solutions, named Dale Ray vice president of sales and marketing. Ray has served as field manager for Philips Medical, vice president of sales and marketing for Fischer Imaging, and has held various management positions with Marconi Medical Systems. He will report to Gary Nie, vice president of integrated services, and will develop the companys worldwide sales force.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.